Digital Transformation Sponsor LLC - Sep 20, 2023 Form 4 Insider Report for American Oncology Network, Inc. (AONC)

Role: 10%+ Owner
Signature: /s/ Kevin Nazemi, Manager of Digital Transformation Sponsor LLC
Stock symbol: AONC
Transactions as of: Sep 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/20/2023, 10:24 PM
SEC: View on sec.gov

This filing has been restated, see here for the amended filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AONC	Class A Common Stock	Other	$0	+8.11M		$0.00	8.11M	Sep 20, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AONC	Warrants	Other		+6.11M			0	Sep 20, 2023	Common Stock	0	$11.50	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Class A common stock converted into shares of Class A common stock of American Oncology Network, Inc. ("New AON") through a series of transactions pursuant to that certain Business Combination Agreement, dated June 14, 2023, as amended, by and among the Issuer, American Oncology Network, LLC, a Delaware limited liability company, GEF AON Holdings Corp., a Delaware corporation, and DTOC Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Issuer.
F2	Mr. Kevin Nazemi is manager of Digital Transformation Sponsor LLC (the "Sponsor"). As such, Mr. Nazemi has sole voting and dispositive power with respect to the Class A common shares of New AON owned by the Sponsor and thus is the beneficial owner of such shares.

Content

Represents Class A common stock converted into shares of Class A common stock of American Oncology Network, Inc. ("New AON") through a series of transactions pursuant to that certain Business Combination Agreement, dated June 14, 2023, as amended, by and among the Issuer, American Oncology Network, LLC, a Delaware limited liability company, GEF AON Holdings Corp., a Delaware corporation, and DTOC Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Issuer.

Mr. Kevin Nazemi is manager of Digital Transformation Sponsor LLC (the "Sponsor"). As such, Mr. Nazemi has sole voting and dispositive power with respect to the Class A common shares of New AON owned by the Sponsor and thus is the beneficial owner of such shares.